BWAY logo

BrainsWay (BWAY) Stock

Profile

Sector:

Healthcare

Country:

Israel

IPO:

17 April 2019

Indexes:

Not included

Description:

BrainsWay (BWAY) is a medical technology company that develops non-invasive treatments for mental health disorders. They use deep transcranial magnetic stimulation (dTMS) to help patients with depression and other conditions. Their innovative approach aims to improve mental well-being and provide alternatives to traditional therapies.

Key Details

Price

$10.21

Annual Revenue

$31.79 M(+16.96% YoY)

Annual EPS

-$0.26(+67.50% YoY)

PE Ratio

108.32

Beta

0.40

Events Calendar

Earnings

Next earnings date:

Mar 06, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Mar 06, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

21 Oct '24 HC Wainwright & Co.
Buy
03 Oct '24 Northland Capital Markets
Outperform
16 Sept '24 HC Wainwright & Co.
Buy
08 Aug '24 HC Wainwright & Co.
Buy
07 Aug '24 Northland Capital Markets
Outperform
05 June '24 HC Wainwright & Co.
Buy
09 May '24 Oppenheimer
Outperform
09 May '24 HC Wainwright & Co.
Buy
11 Mar '24 HC Wainwright & Co.
Buy
16 Nov '23 Raymond James
Market Perform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

BrainsWay Reports Promising Feasibility Data Showing Pain Reduction with Deep TMS Therapy
BrainsWay Reports Promising Feasibility Data Showing Pain Reduction with Deep TMS Therapy
BrainsWay Reports Promising Feasibility Data Showing Pain Reduction with Deep TMS Therapy
BWAY
globenewswire.com20 November 2024

BURLINGTON, Mass. and JERUSALEM, Israel, Nov. 20, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd.

BrainsWay Reports Third Quarter 2024 Financial Results and Operational Highlights
BrainsWay Reports Third Quarter 2024 Financial Results and Operational Highlights
BrainsWay Reports Third Quarter 2024 Financial Results and Operational Highlights
BWAY
globenewswire.com12 November 2024

Robust 26% Year-over-Year Revenue Growth in Q3 2024 Raising Full-Year 2024 Revenue Guidance to $40-41 Million and Initiating Profitability Guidance Conference Call to be Held Today at 8:30 AM ET BURLINGTON, Mass. and JERUSALEM, Israel, Nov. 12, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd.

Brainsway (BWAY) Is a Great Choice for 'Trend' Investors, Here's Why
Brainsway (BWAY) Is a Great Choice for 'Trend' Investors, Here's Why
Brainsway (BWAY) Is a Great Choice for 'Trend' Investors, Here's Why
BWAY
zacks.com06 November 2024

Brainsway (BWAY) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

Is Brainsway (BWAY) Stock Outpacing Its Medical Peers This Year?
Is Brainsway (BWAY) Stock Outpacing Its Medical Peers This Year?
Is Brainsway (BWAY) Stock Outpacing Its Medical Peers This Year?
BWAY
zacks.com31 October 2024

Here is how Brainsway Ltd. Sponsored ADR (BWAY) and Intuitive Surgical, Inc. (ISRG) have performed compared to their sector so far this year.

BrainsWay to Report Third Quarter 2024 Financial Results On November 12, 2024
BrainsWay to Report Third Quarter 2024 Financial Results On November 12, 2024
BrainsWay to Report Third Quarter 2024 Financial Results On November 12, 2024
BWAY
globenewswire.com29 October 2024

BURLINGTON, Mass. and JERUSALEM, Oct. 29, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that it will report its third quarter 2024 financial results as well as operational highlights before the open of the U.S. financial markets on Tuesday, November 12, 2024. The Company will host a conference call and webcast at 8:30 AM Eastern Time to discuss the results and provide an update on business operations.

Wall Street Analysts Believe Brainsway (BWAY) Could Rally 32.01%: Here's is How to Trade
Wall Street Analysts Believe Brainsway (BWAY) Could Rally 32.01%: Here's is How to Trade
Wall Street Analysts Believe Brainsway (BWAY) Could Rally 32.01%: Here's is How to Trade
BWAY
zacks.com21 October 2024

The consensus price target hints at a 32% upside potential for Brainsway (BWAY). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

BrainsWay Further Penetrates East Asia with Placement of 15 Additional Deep TMS™ Systems in Taiwan and South Korea
BrainsWay Further Penetrates East Asia with Placement of 15 Additional Deep TMS™ Systems in Taiwan and South Korea
BrainsWay Further Penetrates East Asia with Placement of 15 Additional Deep TMS™ Systems in Taiwan and South Korea
BWAY
globenewswire.com09 October 2024

BURLINGTON, Mass. and JERUSALEM, Israel, Oct. 09, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the further expansion of its Deep Transcranial Magnetic Stimulation (Deep TMS™) platform in East Asia through the placement of 15 new systems in Taiwan and South Korea.

Brainsway Ltd. Sponsored ADR (BWAY) Hits Fresh High: Is There Still Room to Run?
Brainsway Ltd. Sponsored ADR (BWAY) Hits Fresh High: Is There Still Room to Run?
Brainsway Ltd. Sponsored ADR (BWAY) Hits Fresh High: Is There Still Room to Run?
BWAY
zacks.com04 October 2024

Brainsway (BWAY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Brainsway (BWAY) is on the Move, Here's Why the Trend Could be Sustainable
Brainsway (BWAY) is on the Move, Here's Why the Trend Could be Sustainable
Brainsway (BWAY) is on the Move, Here's Why the Trend Could be Sustainable
BWAY
zacks.com04 October 2024

Brainsway (BWAY) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

Brainsway (BWAY) Soars 14.5%: Is Further Upside Left in the Stock?
Brainsway (BWAY) Soars 14.5%: Is Further Upside Left in the Stock?
Brainsway (BWAY) Soars 14.5%: Is Further Upside Left in the Stock?
BWAY
zacks.com01 October 2024

Brainsway (BWAY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

FAQ

  • What is the primary business of BrainsWay?
  • What is the ticker symbol for BrainsWay?
  • Does BrainsWay pay dividends?
  • What sector is BrainsWay in?
  • What industry is BrainsWay in?
  • What country is BrainsWay based in?
  • When did BrainsWay go public?
  • Is BrainsWay in the S&P 500?
  • Is BrainsWay in the NASDAQ 100?
  • Is BrainsWay in the Dow Jones?
  • When was BrainsWay's last earnings report?
  • When does BrainsWay report earnings?
  • Should I buy BrainsWay stock now?

What is the primary business of BrainsWay?

BrainsWay (BWAY) is a medical technology company that develops non-invasive treatments for mental health disorders. They use deep transcranial magnetic stimulation (dTMS) to help patients with depression and other conditions. Their innovative approach aims to improve mental well-being and provide alternatives to traditional therapies.

What is the ticker symbol for BrainsWay?

The ticker symbol for BrainsWay is NASDAQ:BWAY

Does BrainsWay pay dividends?

No, BrainsWay does not pay dividends

What sector is BrainsWay in?

BrainsWay is in the Healthcare sector

What industry is BrainsWay in?

BrainsWay is in the Medical Devices industry

What country is BrainsWay based in?

BrainsWay is headquartered in Israel

When did BrainsWay go public?

BrainsWay's initial public offering (IPO) was on 17 April 2019

Is BrainsWay in the S&P 500?

No, BrainsWay is not included in the S&P 500 index

Is BrainsWay in the NASDAQ 100?

No, BrainsWay is not included in the NASDAQ 100 index

Is BrainsWay in the Dow Jones?

No, BrainsWay is not included in the Dow Jones index

When was BrainsWay's last earnings report?

BrainsWay's most recent earnings report was on 12 November 2024

When does BrainsWay report earnings?

The next expected earnings date for BrainsWay is 6 March 2025

Should I buy BrainsWay stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions